Exxura 180mcg Solution for Injection
Marketer
Roche Products India Pvt Ltd
Salt Composition
Interferon Alpha 2A (180mcg)
Overview Exxura 180mcg Solution for Injection
Obinutuzumab 180mcg injectable solution treats follicular lymphoma and hairy cell leukemia by modulating cellular processes and immune responses. Administered intravenously by a healthcare professional, the dosage and frequency are determined individually by your physician based on your condition and may vary. Strict adherence to the prescribed regimen is crucial, as improper usage or overdose can lead to severe adverse effects. While therapeutic benefits may not be immediately apparent, discontinue use only under medical guidance. Common side effects include headache, influenza-like symptoms, diaphoresis, lassitude, and myalgia. This medication may decrease white blood cell counts, increasing infection risk, necessitating regular blood tests monitoring blood cell levels, cardiac function, liver health, and blood glucose. Report any mood alterations, depression, or visual changes promptly. Prior to treatment, disclose any pre-existing cardiac, hepatic, or renal conditions, and all medications, particularly those used for infections, as interactions may occur. This medication is contraindicated during pregnancy; both partners should employ reliable contraception throughout the treatment period.
Primary Ingredients of Exxura 180mcg Solution for Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Exxura 180mcg Solution for Injection
Lymphoma of the follicle | Hairy-cell leukemia
Major Benefits of Exxura 180mcg Solution for Injection:
Your healthcare provider will instruct you on the proper administration of this medication.
Common Side effects of Exxura 180mcg Solution for Injection:
- Decreased appetite
- Decreased calcium level in blood
- Decreased white blood cell count
- Diarrhea
- Fatigue
- Flu-like symptoms
- Hair loss
- Headache
- Joint pain
- Muscle pain
- Nausea
- Rigors
- Sweating
- Vomiting
How to use Exxura 180mcg Solution for Injection:
Your healthcare provider will instruct you on the proper administration of this medication.
How Exxura 180mcg Solution for Injection works:
Injected Exxura (180 mcg) solution regulates immune system function.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Exxura 180mcg injectable solution concurrently with alcohol. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Administering Exxura 180mcg Injection Solution during pregnancy is contraindicated due to established harm to the fetus. Nevertheless, in exceptional life-threatening circumstances, a physician might deem its use justifiable if the potential advantages outweigh the inherent risks. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
Administration of Exxura 180mcg Injection Solution while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Exxura 180mcg Solution for Injection on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with kidney impairment should use Exxura 180mcg injectable solution cautiously. Dosage modification might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The injectable formulation of Exxura (180 mcg) is likely safe for individuals with hepatic impairment. Current evidence indicates dose modification may be unnecessary, though further information is limited. Physician consultation is recommended. Routine monitoring of liver function is advisable during treatment.
What if you forget to take Exxura 180mcg Solution for Injection :
Should you forget a dose of Exxura 180mcg injectable solution, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Exxura 180mcg Solution for Injection
| Label | Value |
|---|---|
| Chemical Category | Interferon signaling |
| Developing Habits | No. |
| Treatment Category | Cancer Treatments |
| Active Class | Interferon proteins |
3,018 People bought this recently